BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $86,111 | -76.5% | 13,413 | -74.2% | 0.00% | -100.0% |
Q2 2023 | $367,178 | -25.2% | 52,082 | -11.5% | 0.00% | 0.0% |
Q1 2023 | $491,059 | +100.3% | 58,880 | +175.7% | 0.00% | – |
Q4 2022 | $245,213 | -63.0% | 21,360 | -59.4% | 0.00% | -100.0% |
Q3 2022 | $663,000 | +165.2% | 52,587 | +122.3% | 0.00% | – |
Q2 2022 | $250,000 | -13.8% | 23,656 | +32.9% | 0.00% | – |
Q1 2022 | $290,000 | +93.3% | 17,806 | +70.8% | 0.00% | – |
Q3 2021 | $150,000 | – | 10,423 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |